An established ex vivo 3D culture platform using patient-derived xenograft (PDX) tumors replicate the anti-tumor efficacy observed in vivo

被引：0
|
作者：
Xu, Xiaoxi
Zhang, Wenna
Xie, Bingying
Bao, Zheng Zheng
Mei, Zhu
Wery, Jean-Pierre
Ning, Jinying
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
609
引用
收藏
页数：4
相关论文
共 50 条
  • [21] 3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING
    Basten, Sander
    Beztsinna, Nataliia
    Grillet, Fanny
    Yan, Kuan
    Meesters, Niels
    van der Meer, Donny
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A212 - A212
  • [22] Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer
    Fong, Eliza Li Shan
    Toh, Tan Boon
    Lin, Xiaoxuan
    Liu, Zheng
    Hooi, Lissa
    Rashid, Masturah Bte Mohd Abdul
    Benoukraf, Touati
    Chow, Edward Kai-Hua
    Huynh, The Hung
    Yu, Hanry
    BIOMATERIALS, 2018, 159 : 229 - 240
  • [23] PDX-derived 3D InSightTM tumor microtissues as ex -vivo human experimental models for evaluating therapeutic responses
    Chiovaro, Francesca
    Agarkova, Irina
    Buschmann, Nicole
    Pichon, Chloe'
    Langova, Teresa
    Maier, Armin
    Schueler, Juli A.
    Guye, Patrick
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Investigation of three dimensional (3D) culture model and an anti-tumor drug screening system using PDX
    Kimura, Takahiro
    Tsunesumi, Shinichiro
    Kakita, Misato
    Enoki, Shigenori
    Katayama, Seiichi
    Yagishita, Shigehiro
    Hamada, Akinobu
    CANCER SCIENCE, 2024, 115 : 1999 - 1999
  • [25] ITCC-P4: Genomic profiling and analyses of pediatric patient tumor and patient-derived xenograft (PDX) models for high throughput in vivo testing
    Gopisetty, Apurva
    Federico, Aniello
    Surdez, Didier
    Iddir, Yasmine
    Zaidi, Sakina
    Saint-Charles, Alexandra
    Waterfall, Joshua
    Saberi-Ansari, Elnaz
    Wierzbinska, Justyna
    Schlicker, Andreas
    Mack, Norman
    Schwalm, Benjamin
    Previti, Christopher
    Weiser, Lena
    Buchhalter, Ivo
    Bottcher, Anna-Lisa
    Sill, Martin
    Autry, Robert
    Estermann, Frank
    Jones, David
    Volckmann, Richard
    Zwijnenburg, Danny
    Eggert, Angelika
    Heidenreich, Olaf
    Iradier, Fatima
    Jeremias, Irmela
    Kovar, Heinrich
    Klusmann, Jan-Henning
    Debatin, Klaus-Michael
    Bomken, Simon
    Hamerlik, Petra
    Hattersley, Maureen
    Witt, Olaf
    Chesler, Louis
    Mackay, Alan
    Gojo, Johannes
    Cairo, Stefano
    Schueler, Julia
    Schulte, Johannes
    Geoerger, Birgit
    Molenaar, Jan J.
    Shields, David J.
    Caron, Hubert N.
    Vassal, Gilles
    Stancato, Louis F.
    Pfister, Stefan M.
    Jaeger, Natalie
    Koster, Jan
    Kool, Marcel
    Schleiermacher, Gudrun
    CANCER RESEARCH, 2023, 83 (07)
  • [26] Assessing the impact of cGAS-STING pathway activation on adoptive cell therapy using a patient-derived 3D ex vivo tumor organoid model
    Pabon, M.
    Pastoor, T.
    Ehrhart, J.
    Kreahling, J.
    Altiok, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S59 - S59
  • [27] Ex vivo 3D micro tumor testing platform to guide patient stratification for clinical development of ADCs
    Koedoot, E.
    Sijsenaar, T.
    van der Meer, D.
    Ceton, L.
    Ottevanger, N.
    Kroep, J.
    Vader, W.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S69 - S69
  • [28] Establishment of a novel in vitro test system for anti-cancer drug development using patient-derived xenograft (PDX) tumor
    Kakinuma, Hideaki
    Tsunesumi, Shinichiro
    Sun, Zhe
    Honbori, Kana
    Morikawa, Takashi
    Enoki, Shigenori
    Katayama, Seiichi
    Shimada, Yukiko
    Inoue, Hiroaki
    Nomura, Taisei
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S247 - S247
  • [29] Anti-tumor activity of ATR inhibitor BAY 1895344 in patient-derived xenograft (PDX) models with DNA damage response (DDR) pathway alterations
    Pico, Christian X. Cruz
    Li, Dali
    Lanier, Christopher D.
    Evans, Kurt
    Raso, Maria G.
    DiPeri, Timothy
    Rizvi, Yasmeen
    Ha, Min Jin
    Chen, Huiqin
    Zhao, Ming
    Akcakanat, Argun
    Zheng, Xiaofeng
    Toruner, Gokce
    Yuca, Erkan
    Scott, Stephen
    Wengner, Antje M.
    Yap, Timothy A.
    Meric-Bernstam, Funda
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [30] Bavituximab modulates tumor microenvironment and activates CD8+tumor infiltrating lymphocytes in a patient-derived 3D ex vivo system of lung cancer
    Altiok, Soner
    Mediavilla-Valera, Melanie
    Kreahling, Jenny
    Noyes, David
    Razabdouski, Tiffany N.
    Kallinteris, Nikoletta L.
    Shan, Joseph
    Antonia, Scott
    CANCER RESEARCH, 2015, 75
12345